TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development & commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
$8.31 +0.79 (10.51%)
As of 08/12/2022 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.